At a glance
- Originator Pfizer
- Class Amides; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyridines; Small molecules; Thiazines
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ocular inflammation
Most Recent Events
- 19 Oct 2000 Profile reviewed but no significant changes made
- 04 Nov 1997 New profile
- 04 Nov 1997 Phase-III clinical trials for Ocular inflammation in USA (Ophthalmic)